OSR Health (OSRHW) Other Accumulated Expenses (2022 - 2026)
OSR Health (OSRHW) posted Other Accumulated Expenses of $978215.0 for Q1 2026, up 0.7% sequentially from $971445.0 in Q4 2025, and down 2.46% YoY from $1.0 million in Q1 2025.
OSR Health (OSRHW) Other Accumulated Expenses (2022 - 2026) Analysis & Trends
OSR Health has reported Other Accumulated Expenses for 5 years, with the latest figure at $978215.0 in Q1 2026.
- Quarterly Other Accumulated Expenses fell 2.46% year-over-year to $978215.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $978215.0 (down 2.46% YoY) and the FY2025 annual result came in at $971445.0, up 1117.7% from the prior year.
- Other Accumulated Expenses rose to $978215.0 in Q1 2026 per OSRHW's latest filing, from $971445.0 in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $2.1 million in Q2 2025 and troughed at $17000.0 in Q4 2022.
- A 5-year average of $466597.6 and a median of $87000.0 in 2024 frame the typical range for Other Accumulated Expenses.
- The sharpest annual moves came in 2025 and 2026: Other Accumulated Expenses jumped 2091.48% in 2025, then fell 2.46% in 2026.
- Over 5 years, Other Accumulated Expenses stood at $17000.0 in 2022, then jumped by 323.53% to $72000.0 in 2023, then rose by 10.8% to $79777.0 in 2024, then jumped by 1117.7% to $971445.0 in 2025, then climbed by 0.7% to $978215.0 in 2026.
- According to Business Quant data, Other Accumulated Expenses over the past three periods registered $978215.0, $971445.0, and $963317.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.97 Bn | 131.12 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.15 Bn | 77.15 Bn | 3.93 Bn |
| 3 | Argenx Se | 62.84 Bn | 57.65 Bn | 1.37 Bn |
| 4 | Moderna | 55.74 Bn | 50.60 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.53 Bn | 36.43 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.32 Bn | 8.93 Bn | 668.28 Mn |
| 8 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - |
| 9 | Insmed | 26.99 Bn | 25.83 Bn | 358.27 Mn |
| 10 | OSR Health | 1.40 Mn | 20.39 Mn | 86,605.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 978,215.00 |
| Dec 31, 2025 | 971,445.00 |
| Sep 30, 2025 | 963,317.00 |
| Jun 30, 2025 | 2.13 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2024 | 79,777.00 |
| Sep 30, 2024 | 87,000.00 |
| Jun 30, 2024 | 97,000.00 |
| Mar 31, 2024 | 87,000.00 |
| Dec 31, 2023 | 72,000.00 |
| Sep 30, 2023 | 17,000.00 |
| Jun 30, 2023 | 17,000.00 |
| Mar 31, 2023 | 17,000.00 |
| Dec 31, 2022 | 17,000.00 |